Abstract
Cancer Biotherapy & RadiopharmaceuticalsVol. 16, No. 6 EditorialMetabolism of Radiometal-Labeled Proteins and Peptides: What are the Real Radiopharmaceuticals in vivo?Carolyn J. AndersonCarolyn J. AndersonSearch for more papers by this authorPublished Online:5 Jul 2004https://doi.org/10.1089/10849780152752056AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited ByCharacterization and Evaluation of 64Cu-Labeled A20FMDV2 Conjugates for Imaging the Integrin αvβ622 January 2014 | Molecular Imaging and Biology, Vol. 16, No. 464 Cu-Labeled Phosphonium Cations as PET Radiotracers for Tumor Imaging1 July 2011 | Bioconjugate Chemistry, Vol. 22, No. 8The biodistribution of [ 153 Gd]Gd-labeled magnetic resonance contrast agents in a transgenic mouse model of renal failure differs greatly from control mice26 October 2010 | Magnetic Resonance in Medicine, Vol. 64, No. 5A novel side-bridged hybrid phosphonate/acetate pendant cyclam: Synthesis, characterization, and 64Cu small animal PET imagingBioorganic & Medicinal Chemistry, Vol. 17, No. 264 Cu-Labeled 2-(Diphenylphosphoryl)ethyldiphenylphosphonium Cations as Highly Selective Tumor Imaging Agents: Effects of Linkers and Chelates on Radiotracer Biodistribution Characteristics3 September 2008 | Bioconjugate Chemistry, Vol. 19, No. 10Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclidesAdvanced Drug Delivery Reviews, Vol. 60, No. 12Effects of Targeting Moiety, Linker, Bifunctional Chelator, and Molecular Charge on Biological Properties of 64 Cu-Labeled Triphenylphosphonium Cations18 April 2008 | Journal of Medicinal Chemistry, Vol. 51, No. 10Bispecific Antibody Pretargeting of Radionuclides for Immuno–Single-Photon Emission Computed Tomography and Immuno–Positron Emission Tomography Molecular Imaging: An Update17 September 2007 | Clinical Cancer Research, Vol. 13, No. 18Radioiodinated versus Radiometal-Labeled Anti–Carcinoembryonic Antigen Single-Chain Fv-Fc Antibody Fragments: Optimal Pharmacokinetics for Therapy18 January 2007 | Cancer Research, Vol. 67, No. 2Radiolabeled Multimeric Cyclic RGD Peptides as Integrin α v β 3 Targeted Radiotracers for Tumor Imaging21 July 2006 | Molecular Pharmaceutics, Vol. 3, No. 5Comparative in Vivo Stability of Copper-64-Labeled Cross-Bridged and Conventional Tetraazamacrocyclic Complexes12 February 2004 | Journal of Medicinal Chemistry, Vol. 47, No. 6 Volume 16Issue 6Dec 2001 To cite this article:Carolyn J. Anderson.Metabolism of Radiometal-Labeled Proteins and Peptides: What are the Real Radiopharmaceuticals in vivo?.Cancer Biotherapy and Radiopharmaceuticals.Dec 2001.451-455.http://doi.org/10.1089/10849780152752056Published in Volume: 16 Issue 6: July 5, 2004PDF download
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call